Trials / Sponsors / Xiaojun Chen
Xiaojun Chen
Academic / Other · 9 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance | Phase 2 / Phase 3 | 2022-07-13 |
| Active Not Recruiting | GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients Atypical Endometrial Hyperplasia, Progesterone Resistance, Obesity | Phase 2 / Phase 3 | 2022-07-13 |
| Recruiting | GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance | Phase 2 / Phase 3 | 2022-07-13 |
| Recruiting | Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity | Phase 2 / Phase 3 | 2022-06-13 |
| Recruiting | Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma Endometrial Carcinoma, Obese, Overweight | Phase 2 / Phase 3 | 2022-05-01 |
| Withdrawn | Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia Atypical Endometrial Hyperplasia, Obese, Fertility Issues | Phase 2 / Phase 3 | 2021-03-20 |
| Active Not Recruiting | Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus Middle-high Risk Endometrial Cancer, Sentinel Lymph Node Sampling, Prognosis | N/A | 2020-02-13 |
| Completed | MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia Endometrial Hyperplasia Without Atypia | Phase 3 | 2019-02-26 |
| Completed | Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Ear Endometrial Atypical Hyperplasia, Endometrial Adenocarcinoma | Phase 2 | 2013-10-01 |